NCT03382938 Dexmedetomidine Wound Infiltration in Cesarean Section
| NCT ID | NCT03382938 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Attikon Hospital |
| Condition | Postoperative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2019-08-23 |
| Primary Completion | 2025-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2019-08-23 with a primary completion date of 2025-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).
Eligibility Criteria
Inclusion Criteria: * pregnancy \>37 weeks, ASA I-II, BMI\<35 Exclusion Criteria: * patient refusal, epilepsy, GERD, morbid obesity, drug allergy, ASA class \>2, presence of atrioventricular block, severe systemic disease, multiple gestation, high risk pregnancy, contraindications to epidural technique, a history of severe systemic disease, recreational drug or alcohol use
Frequently Asked Questions
Who can join the NCT03382938 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03382938 currently recruiting?
Yes, NCT03382938 is actively recruiting participants. Visit ClinicalTrials.gov or contact Attikon Hospital to inquire about joining.
Where is the NCT03382938 trial being conducted?
This trial is being conducted at Athens, Greece.
Who is sponsoring the NCT03382938 clinical trial?
NCT03382938 is sponsored by Attikon Hospital. The trial plans to enroll 100 participants.